Atypical mutation of epidermal growth factor receptor in resected stage I non-small-cell lung cancers

被引：0
|
作者：
Etienne, Harry [1 ,2 ]
Goudou, Tristan [1 ,2 ]
Assouad, Jalal [1 ,2 ]
机构：
[1] Sorbonne Univ, Tenon Hosp, AP HP, Dept Thorac & Vasc Surg, 4 Rue Chine, F-75020 Paris, France
[2] Sorbonne Univ, Expt & Clin Resp Neurophysiol, INSERM, UMRS1158, Paris, France
来源：
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY | 2024年 / 65卷 / 01期
关键词：
Epidermal growth factor receptor; Non-small-cell lung cancer; Tyrosine kinase inhibitors;
D O I：
10.1093/ejcts/ezad428
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Patterns of epidermal growth factor receptor mutation in non-small-cell lung cancers in the Gulf region
    Jazieh, Abdul Rahman
    Jaafar, Iasan
    Jaloudi, Mohammed
    Mustafa, Rasha Saleh
    Rasul, Kakil
    Zekri, Jamal
    Bamefleh, Hanaa
    Gasmelseed, Ahmed
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (06) : 1371 - 1374
  • [2] Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non-Small-Cell Lung Cancer
    Sun, Hai-bo
    Ou, Wei
    Li, Yin
    Fang, Qin
    Qin, Jianjun
    Zhang, Liang
    Wang, Si-yu
    CLINICAL LUNG CANCER, 2013, 14 (04) : 376 - 382
  • [3] High predictive value of epidermal growth factor receptor phosphorylation but not of EGFRvIII mutation in resected stage I non-small cell lung cancer (NSCLC)
    Sonnweber, B
    Dlaska, M
    Skvortsov, S
    Dirnhofer, S
    Schmid, T
    Hilbe, W
    JOURNAL OF CLINICAL PATHOLOGY, 2006, 59 (03) : 255 - 259
  • [4] EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY IN NON-SMALL-CELL LUNG CANCER
    Scagliotti, G. V.
    Novello, S.
    Levra, M. G.
    ANNALS OF ONCOLOGY, 2012, 23 : 12 - 12
  • [5] Epidermal growth factor receptor inhibitors in non-small-cell lung cancer
    Cascone, Tina
    Martinelli, Erika
    Morelli, Maria Pia
    Morgillo, Floriana
    Troiani, Teresa
    Ciardiello, Fortunato
    EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (03) : 335 - 348
  • [6] Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancers Dependent on the Epidermal Growth Factor Receptor Pathway
    Nguyen, Kim-Son H.
    Kobayashi, Susumu
    Costa, Daniel B.
    CLINICAL LUNG CANCER, 2009, 10 (04) : 281 - 289
  • [7] Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer
    Selvaggi, G
    Novello, S
    Torri, V
    Leonardo, E
    De Giuli, P
    Borasio, P
    Mossetti, C
    Ardissone, F
    Lausi, P
    Scaghottil, GV
    ANNALS OF ONCOLOGY, 2004, 15 (01) : 28 - 32
  • [8] Clinical usefulness of gefitinib for non-small-cell lung cancer with a double epidermal growth factor receptor mutation
    Oikawa, Takefumi
    Ohira, Tatsuo
    Otani, Keishi
    Hagiwara, Masaru
    Konaka, Chimori
    Ikeda, Norihiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (02) : 329 - 333
  • [9] Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer
    Takenaka, Tomoyoshi
    Takenoyama, Mitsuhiro
    Yamaguchi, Masafumi
    Toyozawa, Ryo
    Inamasu, Eiko
    Kojo, Miyako
    Toyokawa, Gouji
    Yoshida, Tsukihisa
    Shiraishi, Yoshimasa
    Morodomi, Yosuke
    Hirai, Fumihiko
    Taguchi, Kenichi
    Shimokawa, Mototsugu
    Seto, Takashi
    Ichinose, Yukito
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 47 (03) : 550 - 555
  • [10] Ideal sequencing in Stage IV epidermal growth factor receptor mutant Non-Small-Cell Lung Cancer
    Walia, Meenu
    Singhal, Manish K.
    Kamle, Mangesh S.
    INDIAN JOURNAL OF CANCER, 2022, 59 : S80 - S89
12345